Standardised incidence ratio (SIR) for cancers and 95% CIs for male volunteer firefighters to 31 December 2010 for all male volunteers and for male volunteers that attended incidents compared with the Australian population
| Cancer categories | ICD-10 codes | Volunteer firefighters (n=1 57 931) | Volunteer firefighters who attended incidents (n=1 00 126) | ||||
| O | E | SIR (95% CI) | O | E | SIR (95% CI) | ||
| All malignancies | C00–C43, C45–C97, D45–D46, D47.1, D47.3 | 7057 | 8216.17 | 0.86 (0.84 to 0.88) | 4491 | 5262.53 | 0.85 (0.83 to 0.88) |
| Lip, oral cavity and pharynx | C00–C14 | 245 | 342.79 | 0.71 (0.63 to 0.81) | 159 | 226.43 | 0.70 (0.60 to 0.82) |
| Lip | C00 | 125 | 108.68 | 1.15 (0.96 to 1.37) | 87 | 72.31 | 1.20 (0.96 to 1.48) |
| Digestive organs | C15–C25 | 1297 | 1679.28 | 0.77 (0.73 to 0.82) | 808 | 1071.70 | 0.75 (0.70 to 0.81) |
| Oesophagus | C15 | 77 | 117.63 | 0.65 (0.52 to 0.82) | 57 | 75.10 | 0.76 (0.57 to 0.98) |
| Stomach | C16 | 116 | 166.98 | 0.69 (0.57 to 0.83) | 74 | 106.56 | 0.69 (0.55 to 0.87) |
| Colorectal | C18–C21 | 897 | 1052.62 | 0.85 (0.80 to 0.91) | 553 | 671.79 | 0.82 (0.76 to 0.89) |
| Colon | C18 | 526 | 603.91 | 0.87 (0.80 to 0.95) | 333 | 382.80 | 0.87 (0.78 to 0.97) |
| Rectum | C20 | 301 | 334.48 | 0.90 (0.80 to 1.01) | 181 | 215.49 | 0.84 (0.72 to 0.97) |
| Liver | C22 | 39 | 118.61 | 0.33 (0.23 to 0.45) | 18 | 76.13 | 0.24 (0.14 to 0.37) |
| Pancreas | C25 | 116 | 156.67 | 0.74 (0.61 to 0.89) | 77 | 99.38 | 0.77 (0.61 to 0.97) |
| Respiratory | C30–C38 | 429 | 869.75 | 0.49 (0.45 to 0.54) | 263 | 551.19 | 0.48 (0.42 to 0.54) |
| Larynx | C32 | 36 | 80.74 | 0.45 (0.31 to 0.62) | 22 | 52.48 | 0.42 (0.26 to 0.63) |
| Lung | C33–C34 | 371 | 766.31 | 0.48 (0.44 to 0.54) | 228 | 483.92 | 0.47 (0.41 to 0.54) |
| Melanoma | C43 | 912 | 916.15 | 1.00 (0.93 to 1.06) | 590 | 600.13 | 0.98 (0.91 to 1.07) |
| Mesothelioma | C45 | 42 | 65.17 | 0.64 (0.46 to 0.87) | 22 | 40.95 | 0.54 (0.34 to 0.81) |
| Male reproductive | C60–C63 | 2763 | 2564.17 | 1.08 (1.04 to 1.12) | 1777 | 1627.43 | 1.09 (1.04 to 1.14) |
| Prostate | C61 | 2655 | 2368.28 | 1.12 (1.08 to 1.16) | 1692 | 1497.47 | 1.13 (1.08 to 1.19) |
| Testis | C62 | 99 | 107.14 | 0.92 (0.75 to 1.13) | 81 | 73.35 | 1.10 (0.88 to 1.37) |
| Urinary tract | C64–C68 | 334 | 461.48 | 0.72 (0.65 to 0.81) | 205 | 294.52 | 0.70 (0.60 to 0.80) |
| Kidney | C64 | 196 | 239.97 | 0.82 (0.71 to 0.94) | 130 | 156.06 | 0.83 (0.70 to 0.99) |
| Bladder | C67 | 117 | 195.23 | 0.60 (0.50 to 0.72) | 67 | 122.13 | 0.55 (0.43 to 0.70) |
| Brain and other CNS | C70–C72 | 116 | 134.42 | 0.86 (0.71 to 1.04) | 81 | 88.58 | 0.91 (0.73 to 1.14) |
| Brain | C71 | 114 | 129.27 | 0.88 (0.73 to 1.06) | 80 | 85.15 | 0.94 (0.74 to 1.17) |
| Thyroid and other endocrine | C73–C75 | 62 | 76.25 | 0.81 (0.62 to 1.04) | 33 | 50.62 | 0.65 (0.45 to 0.92) |
| Thyroid | C73 | 58 | 70.30 | 0.83 (0.63 to 1.07) | 30 | 46.70 | 0.64 (0.43 to 0.92) |
| Unknown site | C76–C80, C26, C39 | 101 | 184.25 | 0.55 (0.45 to 0.67) | 59 | 116.81 | 0.51 (0.38 to 0.65) |
| Lymphohaematopoetic | C81–C96, D45, D46, D47.1, D47.3 | 663 | 817.01 | 0.81 (0.75 to 0.88) | 426 | 524.79 | 0.81 (0.74 to 0.89) |
| Hodgkin's disease | C81 | 33 | 38.66 | 0.85 (0.59 to 1.20) | 23 | 25.94 | 0.89 (0.56 to 1.33) |
| NHL | C82–C85 | 267 | 321.54 | 0.83 (0.73 to 0.94) | 181 | 208.63 | 0.87 (0.75 to 1.00) |
| Follicular NHL | C82 | 74 | 79.10 | 0.94 (0.73 to 1.17) | 56 | 52.00 | 1.08 (0.81 to 1.40) |
| Diffuse NHL | C83.3 | 126 | 153.10 | 0.82 (0.69 to 0.98) | 82 | 99.00 | 0.83 (0.66 to 1.03) |
| Myeloma | C90 | 74 | 99.13 | 0.75 (0.59 to 0.94) | 48 | 63.24 | 0.76 (0.56 to 1.01) |
| Leukaemia | C91–C95 | 194 | 216.52 | 0.90 (0.77 to 1.03) | 108 | 139.04 | 0.78 (0.64 to 0.94) |
| MDS | D46 | 42 | 51.74 | 0.81 (0.59 to 1.10) | 31 | 30.57 | 1.01 (0.69 to 1.44) |
| All other cancers* | C40–42, C46–50, C69, C96, C97 | 93 | 105.47 | 0.88 (0.71 to 1.08) | 68 | 69.38 | 0.98 (0.76 to 1.24) |
| Male breast | C50 | 12 | 14.46 | 0.83 (0.43 to 1.45) | 12 | 9.29 | 1.29 (0.67 to 2.26) |
*Includes bone and connective tissue, eye, rare lymphohaematopoetic conditions and cancer of multiple sites.
CNS, central nervous system; E, expected; ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th Revision; MDS, myelodysplastic syndrome; NHL, non-Hodgkin's lymphoma; O, observed.